as Egypt suffered a lot during the pandemic of COVID 19 with limited drug choices, many of
the patients could not acheive viral clearence with the standard module of care teh idea of
introduction of new medications in the treatment protocol of COVID 19 managment. Ivermectin
had shown a promising results in vitro studies and in limited in vivo studies. this clinical
trial may open a new hope for COVID 19 patients as a new and cheap line of treatment